3,827 research outputs found

    Fronto-striatal cognitive deficits at different stages of Parkinson's disease

    Get PDF
    Groups of patients with idiopathic Parkinson's disease, either medicated or unmedicated, were compared with matched groups of normal controls on a computerized battery previously shown to be sensitive to frontal lobe dysfunction, including tests of planning, spatial working memory and attentional set-shifting. In a series of problems based on the 'Tower of London' test, medicated patients with Parkinson's disease were shown to be impaired in the amount of time spent thinking about (planning) the solution to each problem. Additionally, an impairment in terms of the accuracy of the solution produced on this test was only evident in those patients with more severe clinical symptoms and was accompanied by deficits in an associated test of spatial short-term memory. Medicated patients with both mild and severe clinical symptoms were also impaired on a related test of spatial working memory. In contrast, a group of patients who were unmedicated and 'early in the course' of the disease were unimpaired in all three of these tests. However, all three Parkinson's disease groups were impaired in the test of attentional set-shifting ability, although unimpaired in a test of pattern recognition which is insensitive to frontal lobe damage. These data are compared with those previously published from a group of young neurosurgical patients with localized excisions of the frontal lobes and are discussed in terms of the specific nature of the cognitive deficit at different stages of Parkinson's disease

    Cerebral blood flow predicts differential neurotransmitter activity

    Get PDF
    Application of metabolic magnetic resonance imaging measures such as cerebral blood flow in translational medicine is limited by the unknown link of observed alterations to specific neurophysiological processes. In particular, the sensitivity of cerebral blood flow to activity changes in specific neurotransmitter systems remains unclear. We address this question by probing cerebral blood flow in healthy volunteers using seven established drugs with known dopaminergic, serotonergic, glutamatergic and GABAergic mechanisms of action. We use a novel framework aimed at disentangling the observed effects to contribution from underlying neurotransmitter systems. We find for all evaluated compounds a reliable spatial link of respective cerebral blood flow changes with underlying neurotransmitter receptor densities corresponding to their primary mechanisms of action. The strength of these associations with receptor density is mediated by respective drug affinities. These findings suggest that cerebral blood flow is a sensitive brain-wide in-vivo assay of metabolic demands across a variety of neurotransmitter systems in humans

    Cognitive Roles of Anterior and Posterior Pedunculopontine Tegmentum Subregions

    Get PDF
    The pedunculopontine tegmentum (PPT) is part of the mesopontine cholinergic system with distinct anterior and posterior subdivisions. With fast sensory input and descending connections to brainstem locomotor centers, we predict posterior PPT (pPPT) mediates prepulse inhibition of acoustic startle reflex, a form of sensorimotor gating that affects attentional processes. Similar to pPPT cholinergic projections to ventral tegmental area, we predict anterior PPT cholinergic input to substantia nigra regulates dopamine release in striatum, which is important for reinforcement learning. We lesioned the PPT bilaterally in male Sprague Dawley rats with ibotenic acid. Posterior cholinergic cell loss was significantly correlated with prepulse inhibition scores, consistent with our predictions for pPPT mediation of PPI. Anterior cholinergic cell loss was not correlated with performance in cued version of Morris water maze task, though lesions were likely insufficient. These results contribute to investigation of anterior vs. posterior PPT contribution to higher cognitive function

    Cortical circuit alterations precede motor impairments in Huntington's disease mice

    Get PDF
    Huntington's disease (HD) is a devastating hereditary movement disorder, characterized by degeneration of neurons in the striatum and cortex. Studies in human patients and mouse HD models suggest that disturbances of neuronal function in the neocortex play an important role in disease onset and progression. However, the precise nature and time course of cortical alterations in HD have remained elusive. Here, we use chronic in vivo two-photon calcium imaging to longitudinally monitor the activity of identified single neurons in layer 2/3 of the primary motor cortex in awake, behaving R6/2 transgenic HD mice and wildtype littermates. R6/2 mice show age-dependent changes in cortical network function, with an increase in activity that affects a large fraction of cells and occurs rather abruptly within one week, preceeding the onset of motor defects. Furthermore, quantitative proteomics demonstrate a pronounced downregulation of synaptic proteins in the cortex, and histological analyses in R6/2 mice and human HD autopsy cases reveal a reduction in perisomatic inhibitory synaptic contacts on layer 2/3 pyramidal cells. Taken together, our study provides a time-resolved description of cortical network dysfunction in behaving HD mice and points to disturbed excitation/inhibition balance as an important pathomechanism in HD
    corecore